Acorda has moved its entire salesforce over from Ampyra to new launch Inbrija. But it’s not relying solely on that team to get the ball rolling.

A leading pharma trade group updated its guidelines for 2019 to strictly forbid all gifts, or "goodies,” handed out by prescription drugmakers.

Amgen's Evenity is trying to score an approval after cardiovascular red flags derailed it in mid-2017. But analysts aren’t so optimistic.

Last week, Allergan's CEO told investors that Botox “continues to remain very strong” in migraine despite the arrival of three new CGRP drugs. But how…

The balance of spending in medical marketing has shifted from almost 90% directed at healthcare professionals 20 years ago, to just 70%.

Johnson & Johnson knows the immunology market is crowded. But that doesn’t mean it doesn’t still see tons of opportunity there.

Investors had been worried that growth for Regeneron’s Eylea was slowing down, but Monday the company batted away those fears.

Eli Lilly is the first pharma to add pricing information to its DTC TV advertising in a commercial for Trulicity this week, with more on the way.